Cargando…

Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery

Epilepsy is a common neurological disorder in domestic dogs. However, its complex mechanism involves multiple genetic and environmental factors that make it challenging to identify the real pathogenic factors contributing to epilepsy, particularly for idiopathic epilepsy. Conventional genome-wide as...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ze-Jia, Liu, Ye-Mao, Zhu, Qiang, Xia, Jingbo, Zhang, Hong-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862570/
https://www.ncbi.nlm.nih.gov/pubmed/29568349
http://dx.doi.org/10.18632/oncotarget.23719
_version_ 1783308249486852096
author Cui, Ze-Jia
Liu, Ye-Mao
Zhu, Qiang
Xia, Jingbo
Zhang, Hong-Yu
author_facet Cui, Ze-Jia
Liu, Ye-Mao
Zhu, Qiang
Xia, Jingbo
Zhang, Hong-Yu
author_sort Cui, Ze-Jia
collection PubMed
description Epilepsy is a common neurological disorder in domestic dogs. However, its complex mechanism involves multiple genetic and environmental factors that make it challenging to identify the real pathogenic factors contributing to epilepsy, particularly for idiopathic epilepsy. Conventional genome-wide association studies (GWASs) can detect various genes associated with epilepsy, although they primarily detect the effects of single-site mutations in epilepsy while ignoring their interactions. In this study, we used a systems genetics method combining both GWAS and gene interactions and obtained 26 significantly mutated subnetworks. Among these subnetworks, seven genes were reported to be involved in neurological disorders. Combined with gene ontology enrichment analysis, we focused on 4 subnetworks that included traditional GWAS-neglected genes. Moreover, we performed a drug enrichment analysis for each subnetwork and identified significantly enriched candidate anti-epilepsy drugs using a hypergeometric test. We discovered 22 potential drug combinations that induced possible synergistic effects for epilepsy treatment, and one of these drug combinations has been confirmed in the Drug Combination database (DCDB) to have beneficial anti-epileptic effects. The method proposed in this study provides deep insight into the pathogenesis of canine epilepsy and implications for anti-epilepsy drug discovery.
format Online
Article
Text
id pubmed-5862570
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-58625702018-03-22 Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery Cui, Ze-Jia Liu, Ye-Mao Zhu, Qiang Xia, Jingbo Zhang, Hong-Yu Oncotarget Research Paper Epilepsy is a common neurological disorder in domestic dogs. However, its complex mechanism involves multiple genetic and environmental factors that make it challenging to identify the real pathogenic factors contributing to epilepsy, particularly for idiopathic epilepsy. Conventional genome-wide association studies (GWASs) can detect various genes associated with epilepsy, although they primarily detect the effects of single-site mutations in epilepsy while ignoring their interactions. In this study, we used a systems genetics method combining both GWAS and gene interactions and obtained 26 significantly mutated subnetworks. Among these subnetworks, seven genes were reported to be involved in neurological disorders. Combined with gene ontology enrichment analysis, we focused on 4 subnetworks that included traditional GWAS-neglected genes. Moreover, we performed a drug enrichment analysis for each subnetwork and identified significantly enriched candidate anti-epilepsy drugs using a hypergeometric test. We discovered 22 potential drug combinations that induced possible synergistic effects for epilepsy treatment, and one of these drug combinations has been confirmed in the Drug Combination database (DCDB) to have beneficial anti-epileptic effects. The method proposed in this study provides deep insight into the pathogenesis of canine epilepsy and implications for anti-epilepsy drug discovery. Impact Journals LLC 2017-12-27 /pmc/articles/PMC5862570/ /pubmed/29568349 http://dx.doi.org/10.18632/oncotarget.23719 Text en Copyright: © 2018 Cui et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Cui, Ze-Jia
Liu, Ye-Mao
Zhu, Qiang
Xia, Jingbo
Zhang, Hong-Yu
Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
title Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
title_full Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
title_fullStr Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
title_full_unstemmed Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
title_short Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
title_sort exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862570/
https://www.ncbi.nlm.nih.gov/pubmed/29568349
http://dx.doi.org/10.18632/oncotarget.23719
work_keys_str_mv AT cuizejia exploringthepathogenesisofcanineepilepsyusingasystemsgeneticsmethodandimplicationsforantiepilepsydrugdiscovery
AT liuyemao exploringthepathogenesisofcanineepilepsyusingasystemsgeneticsmethodandimplicationsforantiepilepsydrugdiscovery
AT zhuqiang exploringthepathogenesisofcanineepilepsyusingasystemsgeneticsmethodandimplicationsforantiepilepsydrugdiscovery
AT xiajingbo exploringthepathogenesisofcanineepilepsyusingasystemsgeneticsmethodandimplicationsforantiepilepsydrugdiscovery
AT zhanghongyu exploringthepathogenesisofcanineepilepsyusingasystemsgeneticsmethodandimplicationsforantiepilepsydrugdiscovery